Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Classificação em ações #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Preço da ação
$0.5099
Última sincronização: 2024-10-15
Valor de mercado
$7.60M
Variação (1 dia)
2.02%
Variação (1 ano)
0.00%
País
US
Negociar Anew Medical, Inc. (WENA)

Categoria

Lucros da Anew Medical, Inc. (WENA)
Lucros em Jun 2024 TTM: $114.12K
De acordo com os últimos relatórios financeiros da Anew Medical, Inc., os ganhos atuais da empresa são de $114.12K. Em 2022, a empresa teve ganhos de $1.56M, um aumento em relação a aos ganhos de 2021, que foram de $-1.11M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Anew Medical, Inc. de 2021 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$5.27B 4,622,261.26%
US
$1.95B 1,709,242.25%
NL
- -
CH
- -
KR
$3.01B 2,633,790.84%
BE